Gary Thompson

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

Spectrix Therapeutics LLC is a privately held specialty pharmaceutical company. It provide and develops St-ME01, and ST-RHU02. The company was founded by Mark Tengler, John Q. Adams Jr., and John Dyett in 2016 and is headquartered in Southlake, TX.

Center for Global Health Innovation, Inc. is a member of Georgia Bio, a non-profit life sciences association in Georgia. The non-profit company is based in Atlanta, GA. Georgia Bio works with various organizations to shape public policy, improve access to innovative technologies, and grow Georgia's life sciences economy. The CEO of the company is Maria Thacker-Goethe.

Part of Salem Partners LLC, Salem Partners Wealth Management LLC is a company that provides investment advice. The company is based in Los Angeles, CA. John Hathaway Dyett has been the CEO of the company since 2004.

Salem Partners LLC. provides investment banking services. Its services include valuation services, media and entertainment, healthcare and life sciences, aerospace, defense and government services, real estate and transactions. The company was founded by John Dyett and Stephen Prough in 1997 and is headquartered in Los Angeles, CA.

Alydia Health, Inc. operates as medical device company which provides solution to postpartum hemorrhage. The company was founded by Nathan Bair and Jessie Becke on May 8, 2018 and is headquartered in Menlo Park, CA.

Part of Kimberly-Clark Corp., Kimberly-Clark Professional partners with businesses to create exceptional workplaces by offering a range of workplace solutions from well-known and trusted brands like Scott, Kleenex, Kleenguard, Cottonelle, Kimtech, and Wypall. The American company's aim is to make workplaces healthier, safer, and more productive.

Absorbable Polymer Technologies, Inc. develops and manufactures biodegradable polymers for medical and pharmaceutical applications. The company is headquartered in Pelham, AL.

Altea Therapeutics Corp. develops pharmaceutical products. It offers PassPort patch, a skin patch that uses short bursts of focused thermal energy to create tiny channels in the surface of the skin and these channels permit the flow of proteins, peptides, carbohydrates, and small molecules into the body without the use of needles. The firm also provides Transdermal vaccine patch, a delivery system for water-soluble drugs and proteins; disease prevention products; insulin skin patch, a non-injectable daily insulin product; and opioid patches that provide delivery of opioids and incorporates the layers of deterrents. The company was founded by Jonathan A Eppstein and Deborah Eppstein in 1998 and is headquartered in Atlanta, GA.

Vydence Medical - Industria E Comercio Ltda. is a Brazilian company based in Sao Carlos, Brazil. Vydence Medical is the Brazilian largest company in equipment intended for medical aesthetics, focusing on dermatology, vascular surgery, and plastic surgery. The company offers a range of products, including laser hair removal technology, longpulse, dualmode, q-switched laser-acrom-qs, and 1,340 nm-prodeep non-ablative. The company also provides assistance and support services to ensure the safety of medical technology practices. Vydence Medical has a training center in Sao Paulo and an office in the USA. The company was founded in 2016, and Andre Tanaka has been the CEO of the company since 2001.

Cytrellis Biosystems, Inc. designs and develops aesthetic devices. The company was founded by William Gerald Austen and Doug A. Levinson and is headquartered in Boston, MA.

Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA.

Vividion Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. It's proprietary chemoproteomic platform technology addresses the key limitations of conventional screening techniques and allows the discovery of previously unknown, or cryptic, functional pockets on the surface of proteins and identification of small molecules that selectively bind to those targets. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke on December 24, 2013 and is headquartered in San Diego, CA.

Adavium Medical, Inc. engages in the provision of medical equipment and diagnostics services. The company was founded by Fred Aslan is headquartered in Sao Paulo, Brazil.

Vyttra Diagnosticos Importacao E Exportacao Ltda. commercializes and distributes medical equipments. The company was founded by Fred Aslan on February 25, 2011 and is headquartered in São Paulo, Brazil.

Advance Medical, Inc. operates medical hospital and provides home health care services. It offers medical opinions, behavioral care, virtual medical care, pharmaceutical management, and enterprise solutions. The company was founded by Michael Hough in 1999 and is headquartered in Westwood, MA.

The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA.

Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts.

Venrock Associates is an Independent Venture Capital firm founded in 1969. The firm is headquartered in Palo Alto.

CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT.

4P Therapeutics LLC develops pharmaceutical products. It offers abuse deterrent fentanyl transdermal system, scopolamine, follicle stimulating hormone, and exenatide products. It also offers preclinical feasibility, engineering, manufacturing, clinical research, regulatory affairs, quality assurance, and project management. The company was founded by Alan Smith and Steven Damon in 2011 and is headquartered in Peachtree Corners, GA.

Temple Therapeutics BV is a Dutch company that focuses on developing treatments and early detection diagnostics for tissue fibrosis, endometriosis, and ovarian cancer. Temple Therapeutics is based in Geleen, NL. The private company uses scientific innovations and a novel cellular metabolism approach to create a pipeline of highly differentiated diagnostic and drug candidates. The company prioritizes women's healthcare and aims to provide life-changing innovations. The company was founded in 2015, and the CEO is Sanj Singh.

Micron Biomedical, Inc. develops pharmaceutical products. It provides protective (vaccine) and therapeutic (drugs) effects, superior patient compliance, and simplified administration, distribution and storage logistics. The company was founded by Mark Prausnitz, Devin McAllister and Sebastien Henry and is headquartered in Atlanta, GA.

Front Porch Communities & Services engages in providing adult day care services and retirement communities care services. The company is headquartered in Glendale, CA.

Part of ICON plc, PRA International LLC is a clinical research organization. The company is based in Raleigh, NC.

Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY.

May Health SAS engages in the development of device for the treatment of polycystic ovary syndrome infertility. The company was founded in September 2017 and is headquartered in Paris, France.

Ark Surgical Ltd. is an Israeli medical device company that specializes in the commercialization of the LapBox tissue containment removal system. The company is based in Israel and was founded by Abraham Yaari, Aaron Feldman. The LapBox is a safe and minimally-invasive alternative for gynecologists using laparoscopic surgery. The company was founded by medical device veterans with hands-on experience in the clinical setting and operates as a portfolio company of the NGT³ venture capital fund. The CEO is Stav Tori.

Vivant Medical, Inc. develops microwave ablation system. It offers treatment of benign and cancerous soft tissue tumors. The company was founded by Thomas J. Fogarty on October 39, 1998 and is headquartered in Mountain View, CA.

AsclepiX Therapeutics LLC engages in biologics and drug development technology. It specializes in anti-angiogenesis therapy, ophthalmology, oncology, and immunology. The company was founded by Jordan J. Green and Aleksander S. Popel and is headquartered in Baltimore, MD.

Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical Company focused on the discovery, development and commercialization of pharmaceutical products to treat autoimmune and inflammatory diseases and is based in Baltimore, Maryland. Genetics, environment, aberrant immune response, and barrier dysfunction are all required for autoimmunity. Alba's technology platform is based on modifying disease state epithelial permeability using compounds which impact the regulation of tight junctions in cell barriers throughout the body with potential applications in celiac disease, Crohn's disease, asthma/COPD and acute lung injury. As a development stage company Alba maximizes value creation by leveraging its human capital, partnerships and technology. Since the Company's formation in 2004, the company has entered human clinical trials with its lead product, received Fast Track designation from the FDA (in Celiac Disease), successfully completed three Phase I clinical trials and completed its first Phase II study. Along with $30m raised in its Series A financing, equity and non-equity capital, such as SBIR and ATP grants and venture debt, are being used to develop products, enhance its powerful IP position and build the Company's infrastructure and core competencies